Medical Services International Moves VScan Into England
12 Septembre 2006 - 7:04PM
PR Newswire (US)
EDMONTON, Alberta, Sept. 12 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (OTC:MSITF) is pleased to announce that
it has signed a distribution agreement with a pharmaceutical
company for England. The distributor is responsible for all
regulatory approvals required to begin selling in England. With the
number of approvals already received (28 countries) plus the
testing that has been completed in the United States, Canada, China
and Europe, it is felt that regulatory approval in England can be
completed within 60 to 90 days. In addition to the above, the kits
for England will be produced from the Companies India facility that
already has a GMP certificate and a ISO 9001 Quality control
rating. It is expected that the Company will sell in excess of 1.0
million kits in England in the first year generating gross revenues
in excess of 3.0 million US dollars. The demand for VScan test kits
continues grow as testing in the different countries shows that
they are accurate and easy to use. The VScan test kits are able to
meet and exceed all regulatory standards. The demand for the VScan
kits will continue to grow as more and more people become familiar
with its performance. Medical Services International Inc. trades in
the United States on the NQB Pinksheets under the symbol "MSITF".
For further information, please contact Robert Talbot at (780) 430
6363 or http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International,
+1-780-430-6363 Web site: http://www.minerva-biotech.com/
http://www.medicalservicesintl.com/
Copyright